Xencor
(NASDAQ) XNCR
Xencor Financials at a Glance
Market Cap
$884.46M
Revenue (TTM)
$125.58M
Net Income (TTM)
$91.92M
EPS (TTM)
$-1.24
P/E Ratio
-9.71
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Price
$12.51
Volume
107,306.868
Open
$12.35
Price
$12.51
Volume
107,306.868
Open
$12.35
Previous Close
$12.06
Daily Range
$12.17 - $12.73
52-Week Range
$6.92 - $18.69
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Price
$12.51
Volume
107,306.868
Open
$12.35
Previous Close
$12.06
Daily Range
$12.17 - $12.73
52-Week Range
$6.92 - $18.69
XNCR News
Why Shares of Zencor Rose This Week
3 Biotech Stocks to Buy in February
XNCR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Xencor
Industry
Biotechnology
Sector
Health CareEmployees
260
CEO
Bassil I. Dahiyat, PhD
Website
www.xencor.comHeadquarters
Pasadena, CA 91016, US
XNCR Financials
Key Financial Metrics (TTM)
Gross Margin
94%
Operating Margin
-1%
Net Income Margin
-73%
Return on Equity
-14%
Return on Capital
-23%
Return on Assets
-10%
Earnings Yield
-10.30%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$884.46M
Shares Outstanding
73.34M
Volume
107.31K
Short Interest
0.00%
Avg. Volume
787.80K
Financials (TTM)
Gross Profit
$115.06M
Operating Income
$177.50M
EBITDA
$46.98M
Operating Cash Flow
$135.12M
Capital Expenditure
$3.15M
Free Cash Flow
$138.27M
Cash & ST Invst.
$547.73M
Total Debt
$187.75M
Xencor Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$28.24M
-59.7%
Gross Profit
$25.66M
-63.4%
Gross Margin
90.87%
N/A
Market Cap
$884.46M
N/A
Market Cap/Employee
$3.54M
N/A
Employees
250
N/A
Net Income
$6.65M
+87.6%
EBITDA
$5.67M
+136.1%
Quarterly Fundamentals
Net Cash
$359.99M
+35.4%
Accounts Receivable
$29.30M
-51.8%
Inventory
$0.00
N/A
Long Term Debt
$141.22M
-21.8%
Short Term Debt
$46.53M
-9.6%
Return on Assets
-10.50%
N/A
Return on Invested Capital
-22.77%
N/A
Free Cash Flow
$52.85M
+9.3%
Operating Cash Flow
$51.71M
+7.0%